Catalyst Wire Dossier Catalyst Wire Dossier

blisibimod

blisibimod · Anthera Pharmaceuticals
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for blisibimod, covering 2015-07-30 to 2017-09-18. Get the full timeline:

Most recent: Clinical Trial Update: BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration [Phase 2, Phase 3]

See pricing